Publicacións (83) Publicacións de MARIA DOLORES VIÑA CASTELAO

2024

  1. Potent, selective and reversible hMAO-B inhibition by benzalphthalides: Synthesis, enzymatic and cellular evaluations and virtual docking and predictive studies

    Bioorganic Chemistry, Vol. 146

2023

  1. 8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies

    European Journal of Medicinal Chemistry, Vol. 248

  2. Phytochemical Analysis and Antiproliferative Activity of Ulex gallii Planch. (Fabaceae), a Medicinal Plant from Galicia (Spain)

    Molecules, Vol. 28, Núm. 1

2022

  1. Antitumor activity of copper(II) complexes with Schiff bases derived from N′-tosylbenzene-1,2-diamine

    Journal of Inorganic Biochemistry, Vol. 236

  2. Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin

    Molecules, Vol. 27, Núm. 3

  3. Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 37, Núm. 1, pp. 973-985

  4. Nanomolar resveratrol reduces early alterations of pancreatitis and pancreatic cancer in pancreatic acinar cells

    Phytomedicine Plus, Vol. 2, Núm. 3

2021

  1. 7-Amidocoumarins as Multitarget Agents against Neurodegenerative Diseases: Substitution Pattern Modulation

    ChemMedChem, Vol. 16, Núm. 1, pp. 179-186

  2. Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors

    Bioorganic Chemistry, Vol. 108

  3. Curcumin–coumarin hybrid analogues as multitarget agents in neurodegenerative disorders

    Molecules, Vol. 26, Núm. 15

  4. Gamma-decanolactone: Preliminary evaluation as potential antiparkinsonian drug

    European Journal of Pharmacology, Vol. 906

  5. Pyridazinones containing dithiocarbamoyl moieties as a new class of selective MAO-B inhibitors

    Bioorganic Chemistry, Vol. 115

  6. Synthesis and in vitro study of nitro- and methoxy-2-phenylbenzofurans as human monoamine oxidase inhibitors

    Bioorganic Chemistry, Vol. 107

  7. Synthesis, Pharmacological, and Biological Evaluation of 2-Furoyl-Based MIF-1 Peptidomimetics and the Development of a General-Purpose Model for Allosteric Modulators (ALLOPTML)

    ACS Chemical Neuroscience, Vol. 12, Núm. 1, pp. 203-215

  8. cAMP Compartmentalization in Cerebrovascular Endothelial Cells: New Therapeutic Opportunities in Alzheimer's Disease

    Cells, Vol. 10, Núm. 8

2020

  1. 3-Arylcoumarins as highly potent and selective monoamine oxidase B inhibitors: Which chemical features matter?

    Bioorganic Chemistry, Vol. 101

  2. 8-propyl-6H-[1,3]dioxolo[4,5-g]chromen-6-one: A new coumarin with monoamine oxidase B inhibitory activity and possible anti-parkinsonian effects

    Brazilian Journal of Pharmaceutical Sciences, Vol. 56

  3. Coumarin-Rasagiline Hybrids as Potent and Selective hMAO-B Inhibitors, Antioxidants, and Neuroprotective Agents

    ChemMedChem, Vol. 15, Núm. 6, pp. 532-538

  4. Discovery and optimization of 3-thiophenylcoumarins as novel agents against Parkinson's disease: Synthesis, in vitro and in vivo studies

    Bioorganic Chemistry, Vol. 101

  5. Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy

    Bioorganic Chemistry, Vol. 104